ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
FRA:ABL - Deutsche Boerse Ag - US0028241000 - Common Stock - Currency: EUR
Taking everything into account, ABL scores 6 out of 10 in our fundamental rating. ABL was compared to 55 industry peers in the Health Care Equipment & Supplies industry. ABL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ABL has a correct valuation and a medium growth rate. These ratings could make ABL a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year ABL was profitable.
In the past year ABL had a positive cash flow from operations.
In the past 5 years ABL has always been profitable.
In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 16.46%, ABL belongs to the top of the industry, outperforming 92.73% of the companies in the same industry.
ABL has a better Return On Equity (28.12%) than 94.55% of its industry peers.
The Return On Invested Capital of ABL (8.98%) is better than 81.82% of its industry peers.
ABL had an Average Return On Invested Capital over the past 3 years of 10.45%. This is above the industry average of 8.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.46% | ||
| ROE | 28.12% | ||
| ROIC | 8.98% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
The Profit Margin of ABL (31.95%) is better than 98.18% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
ABL has a better Operating Margin (16.77%) than 83.64% of its industry peers.
ABL's Operating Margin has improved in the last couple of years.
ABL has a Gross Margin of 55.66%. This is comparable to the rest of the industry: ABL outperforms 50.91% of its industry peers.
ABL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.77% | ||
| PM (TTM) | 31.95% | ||
| GM | 55.66% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ABL has about the same amount of shares outstanding.
The number of shares outstanding for ABL has been reduced compared to 5 years ago.
Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
ABL has an Altman-Z score of 5.95. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
ABL's Altman-Z score of 5.95 is amongst the best of the industry. ABL outperforms 94.55% of its industry peers.
ABL has a debt to FCF ratio of 2.22. This is a good value and a sign of high solvency as ABL would need 2.22 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.22, ABL belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
ABL has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
ABL's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. ABL outperforms 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 2.22 | ||
| Altman-Z | 5.95 |
ROIC/WACC1.04
WACC8.65%
2.3 Liquidity
A Current Ratio of 1.67 indicates that ABL should not have too much problems paying its short term obligations.
The Current ratio of ABL (1.67) is comparable to the rest of the industry.
A Quick Ratio of 1.23 indicates that ABL should not have too much problems paying its short term obligations.
The Quick ratio of ABL (1.23) is better than 67.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.23 |
3. Growth
3.1 Past
ABL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.18%.
The Earnings Per Share has been growing slightly by 7.59% on average over the past years.
Looking at the last year, ABL shows a small growth in Revenue. The Revenue has grown by 4.59% in the last year.
ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.63% yearly.
EPS 1Y (TTM)5.18%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%12.61%
Revenue 1Y (TTM)4.59%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.16%
3.2 Future
ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.45% yearly.
Based on estimates for the next years, ABL will show a small growth in Revenue. The Revenue will grow by 6.86% on average per year.
EPS Next Y11.5%
EPS Next 2Y11.05%
EPS Next 3Y10.99%
EPS Next 5Y10.45%
Revenue Next Year5.6%
Revenue Next 2Y6.53%
Revenue Next 3Y6.8%
Revenue Next 5Y6.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.15, the valuation of ABL can be described as expensive.
ABL's Price/Earnings ratio is a bit cheaper when compared to the industry. ABL is cheaper than 72.73% of the companies in the same industry.
When comparing the Price/Earnings ratio of ABL to the average of the S&P500 Index (29.35), we can say ABL is valued inline with the index average.
With a Price/Forward Earnings ratio of 26.13, ABL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
ABL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.15 | ||
| Fwd PE | 26.13 |
4.2 Price Multiples
ABL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 67.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.16 | ||
| EV/EBITDA | 23.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.54
PEG (5Y)3.84
EPS Next 2Y11.05%
EPS Next 3Y10.99%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.75%, ABL has a reasonable but not impressive dividend return.
ABL's Dividend Yield is a higher than the industry average which is at 2.13.
Compared to the average S&P500 Dividend Yield of 2.33, ABL is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.75% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
28.62% of the earnings are spent on dividend by ABL. This is a low number and sustainable payout ratio.
The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.62%
EPS Next 2Y11.05%
EPS Next 3Y10.99%
FRA:ABL (3/7/2025, 7:00:00 PM)
125.34
-0.34 (-0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners79.14%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap217.38B
Analysts80
Price Target130.12 (3.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.75% |
Yearly Dividend2.04
Dividend Growth(5Y)11.4%
DP28.62%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.75%
Min EPS beat(2)-1.16%
Max EPS beat(2)-0.34%
EPS beat(4)2
Avg EPS beat(4)0.58%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.22%
EPS beat(8)5
Avg EPS beat(8)1.17%
EPS beat(12)9
Avg EPS beat(12)6.97%
EPS beat(16)13
Avg EPS beat(16)9.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)-0.15%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)7
Avg Revenue beat(12)2.21%
Revenue beat(16)10
Avg Revenue beat(16)2.94%
PT rev (1m)1.05%
PT rev (3m)3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.5%
EPS NY rev (1m)0.11%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.62%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-1.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.15 | ||
| Fwd PE | 26.13 | ||
| P/S | 5.63 | ||
| P/FCF | 37.16 | ||
| P/OCF | 27.58 | ||
| P/B | 4.95 | ||
| P/tB | 13.18 | ||
| EV/EBITDA | 23.58 |
EPS(TTM)4.3
EY3.43%
EPS(NY)4.8
Fwd EY3.83%
FCF(TTM)3.37
FCFY2.69%
OCF(TTM)4.54
OCFY3.63%
SpS22.28
BVpS25.31
TBVpS9.51
PEG (NY)2.54
PEG (5Y)3.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.46% | ||
| ROE | 28.12% | ||
| ROCE | 10.46% | ||
| ROIC | 8.98% | ||
| ROICexc | 10.19% | ||
| ROICexgc | 20.46% | ||
| OM | 16.77% | ||
| PM (TTM) | 31.95% | ||
| GM | 55.66% | ||
| FCFM | 15.14% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexcg growth 3Y-24.08%
ROICexcg growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 2.22 | ||
| Debt/EBITDA | 1.23 | ||
| Cap/Depr | 68.58% | ||
| Cap/Sales | 5.26% | ||
| Interest Coverage | 11.65 | ||
| Cash Conversion | 83.46% | ||
| Profit Quality | 47.39% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.23 | ||
| Altman-Z | 5.95 |
F-Score7
WACC8.65%
ROIC/WACC1.04
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)5.18%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%12.61%
EPS Next Y11.5%
EPS Next 2Y11.05%
EPS Next 3Y10.99%
EPS Next 5Y10.45%
Revenue 1Y (TTM)4.59%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%7.16%
Revenue Next Year5.6%
Revenue Next 2Y6.53%
Revenue Next 3Y6.8%
Revenue Next 5Y6.86%
EBIT growth 1Y4.67%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.83%
EBIT Next 3Y15.14%
EBIT Next 5Y10.88%
FCF growth 1Y25.54%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y17.86%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%